Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-18

Clinical Trial Update: Use of iPro™2 in Real Life Diabetes Management of Type 2 Patients in India [NA]

View source ↗

Summary

A completed clinical trial update on the iPro2 device for real-world management of Type 2 diabetes in India with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • iPro™2

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED | Results posted: 2018-10-18